IQV Stock: IQVIA Holdings Inc. Stock Price, Analysis & Insights
Get live iqv stock price $217.28, comprehensive IQVIA Holdings Inc. stock analysis, charts, news, and expert forecast. Real-time iqv stock data and investment insights.
Loading chart...
Company Overview
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a strategic collaboration with HealthCore, Inc. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.
Company Information
- CEO
- Ari Bousbib
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Employees
- 89000
Contact Information
- Website
- https://www.iqvia.com
- Address
- 4820 Emperor boulevard
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 29.9)
✓ Higher growth potential with elevated volatility (Beta: 1.38)
Business Model & Strategy
IQVIA Holdings Inc. operates in the Medical - Diagnostics & Research industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO Ari Bousbib, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Medical - Diagnostics & Research model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
IQVIA Holdings Inc. competes in the Medical - Diagnostics & Research within the broader Healthcare. With 37.0 billion in market capitalization, the company is positioned as a established player in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the New York Stock Exchange, IQVIA Holdings Inc. provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating IQVIA Holdings Inc. should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for IQVIA Holdings Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for mid-cap stocks
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for IQVIA Holdings Inc.
- ⚠Investors should consider how IQVIA Holdings Inc. fits within their overall portfolio allocation
Market Cap
37.00B
P/E Ratio
29.93
Beta
1.38
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 37.00B market capitalization
- Trading Volume: 1.14M shares traded today
- Price Range: 52-week range of $134.65 - $228.12
- Exchange: Listed on New York Stock Exchange
Financial Metrics
Market Analysis for IQVIA Holdings Inc.
IQVIA Holdings Inc. (IQV) operates in the Medical - Diagnostics & Research industry within the Healthcare sector. With a current market capitalization of 37.00B, the company represents a significant player in its market. The stock is currently trading at $217.28 with a positivedaily change of 0.54%.
The company's 89000 employee base and presence on the New York Stock Exchangeexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of 29.93, beta of 1.38, and 52-week price range from $134.65 to $228.12when evaluating investment opportunities.
Why Invest in IQVIA Holdings Inc.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (New York Stock Exchange)
- • Experienced leadership under Ari Bousbib
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.